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Activation of cytotoxic Τ lymphocytes in HLA-A, -B
and -C-identical responder-stimulator pairs II
New subtypes of HLA-Bw35
MARIUN Η BREUNING, BIRGITTA S BREUR, MARIAN Υ ENGELSMA, ELS GOULMY* and PAVOL
IVANYI
Central Labor atory of the Netherlands Red Cross Blood Transfusion Service and Laboratory for
Expenmental and Clmicdl Immunology of the Umversity of Amsterdam, Amsterdam, and ^Department
of Immunohematology, Blood Bank, Umversity Hospital, Leiden, The Netherlands
We compared five cytotoxic Τ lymphocytes raised by pnmary mixed lymphocytc
cultures of HLA A, -B and C scrologically identical Bw35 positive responder
stimulator combinations When tested on a panel of third party target cells, the
reactivity pattern of these cytotoxic Τ lymphocytes allowed the distinction of three
subtypes of HLA-Bw35 Cold-target Inhibition expenments and analysis of CTL
activity at the clonal level showed the existence of subsets of C TLs directed against
distinct antigemc determinants associated with HLA Bw35
Received for publiLation 19 December 1983, aeeepted 28 May 1984
Cytotoxic Τ lymphocytes (CTLs) can be used
lo discnmindte subtypes of serologically de-
üned HLA Α and -B antigens (Bradley et al
1978, Breuning et al 1982, Goulmy et al
1976, Horai et al 1982, Kato et al 1980, Spits
et al 1982, Tekolf et al 1982) According to
these reports, Cl Ls can deftne subtypes of
HLA antigens on HLA molecules that are at
present not recognized by currently available
(monospecific) HLA-typmg sera HLA-anti-
gen subtypes can also be recognized by virus-
specific and Η Y-spetific, HLA-restncted
ClLs (Biddison et al 1980a, Biddison et al
1981, Breuning et al 1982, Goulmy et al
1982) and may bc relevant for studies of the
role of HLA antigens in tissue transplantation
and in HLA-associated diseases The reper-
toire of the allogeneic CTLs can be used to
unravel the complexity of the HLA antigens
We have generated CTLs in a series of re-
sponder stimulator pairs matched for
serologically defined HLA-A, -B and -C anti-
gens (Breuning et al 1984 I) In this report,
we desenbe three CTLs Irom this senes which
scem to detect subtypes of the HLA-Bw35
antigen In addition, the specificity of these
CTLs IS compared with Bw35 subtype-specific
CTLs previously desenbed (Bradley et al
1978, Goulmy et al 1976) The results mdi-
cate that at least three distinct types of HLA-
Bw35 exist
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Material and methods
Lymphocytes were obtained from HLA-A,
-B, -C and -DR-typed individuals from the
Dutch population. Isolation, cryopreservation
and thawing of the peripheral blood lympho-
cytes (PBL) have been described by Breuning
et al. (1982).
HLA phenotypes of the cells used for the
generation of CTLs are shown in Table 1.
Typing for CTL-defined subtypes of HLA-B27
was performed as described by Breuning et al.
(1982) and Breuning et al. (1983). In all com-
binations, there was an HLA-DR difference
and a significant proliferation in mixed lym-
phocyte culture (MLC), as measured by the
incorporation of 3H-thymidine after 5 days of
culture (Breuning et al. 1984 I).
One of the donors (cell no. 345) was a
patient with ankylosing spondylitis from
Spanish origin. Cells from one pair of homo-
zygous twins (cells no. 265 and 266) were used
alternatively. In several experiments, the lat-
ter cells were found to be interchangeable
(data not shown). Responder cells as well as
stimulator cells (irradiated with 2000 rad from
a
 l37Cs source) were cultured for 6 days at a
1:1 ratio in Iscove's modified Dulbecco's me-
dium (IMDM; Gibco) with 100 IU penicillin
and 100 μg streptomycin/ml, supplemented
with 20% pooled human serum. PBL,
cultured for 6 days in the same medium with-
out any stimulant, were used as target cells.
After 6 days, 2.105,105 and 5.104 effector cells
were incubated with 2.104 51Cr-labelled target
cells for 8 h in IMDM with 100 IU penicillin
and 100 μg streptomycin/ml, supplemented
with 10% heat-inactivated foetal calf serum
(FCS; Gibco). The percentage of cytotoxicity
was calculated according to the formula 100 x
(ER - SR)/(MR - SR), counts per minute of
the median of triplicate experiments, where
ER is the experimental release of chromium,
SR the spontaneous release from target cells
incubated in medium alone, and MR the re-
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lease from cells lysed with saponin, the maxi-
mal release
Cold-target Inhibition expenments were
performed as descnbed by Breuning et al
(1983) Unlabelled PBL, cultured for 3 days
without any stimulant, were used as cold tar-
get cells Unlabelled lymphocytes, 2 5 x 10'
or 5 10\ were added to wells containing 105
effector cells and 5 101 ^Cr-labelled target
cells correspondmg to cold/hot-target ratios of
50 1 or 100 1 and to an effector/hot-target-cell
ratio of 20 1 The rclcase time was 5'/> h The
percentage 51Cr release was calculated as de-
scnbed above Most CML tests were repeated
two to three times, and the mean value is
shown in this work
Results
Panel studies
The Cl Ls used are listed in Table 1 CTLs 9
and 10 were raised by reciprocal one-way-
mixed lymphocyte cultures of HLA-A, -B
and -C-identical cells obtained from two unre-
lated blood donors The CTLs were tested on
a large panel of third-party target cells from
unrelated individuals (Figure 1) Although
the responder cells used for the generation of
CTL 10 themselves expressed HLA-Bw35,
CTL 10 lysed all samples of Bw35 positive
target teils except two One of the latter two
samples were the autologous target cells
CTL 9, on the contrary, strongly lysed only
the target cells from the stimulator as well as
the one exceptional sample of third-party
Bw35 target cells that were not lysed by CTL
10 (Figure 1) These results suggest that the
two target cells not recognized by CTL 10
carry a vanant HLA-Bw35 antigen The anti-
genic determinant recognized by CTL 10 was
iound to segregate with an HLA-Bw35-posi-
tive haplotype in several famihes (results not
shown)
CTL 17 was also raised by MLC of
ο
-J
ÖO
50
40
30
20
10
0
* i
•··
a Β
Β
- a
 β
Β
Β
ΒΒα %
/ν
• · οο*
Ö
ο
 π
β
ο ο
00 0 Δ
ο οο°
οοο°
8ο° Ä
1
•
6
Δ
•
•ο
Δ
ο
. · *
ο
10 20 30 40 50
CTL9-% Cr release
Figure 1 Cytolytic activity of CTLs 9 and 10 against
target cells from 79 unrelated individuals ir, re
spondcr/stimulator cells, O, Bw35-, 9, Bw35+, D,
Bw35- DR1 + , • Bw35+ DR1 + , Δ, Bw35-
DR7+, Α, Β\ν3"ϊ + DR7+ The effector/target-cell
ratio was 10 1
serologically HLA-A, -B, -C-identical,
D/DR-different responder-stimulator com-
binalions (Table 1, Breuning et al 1984 I)
Imtially, wc tested CTL 17 on a panel of 60
samples of target cells from unrelated indivi-
duals CTL 17 showed cytotoxicity on 12 of
these target teils, all of which expressed the
HLA antigen Bw35 However, 28 HLA-
Bw35-positive target cells were not lysed by
CTL 17, neither were any of the remaining 20
Bw35 negative target cells (results not
shown) Thus, there being no serologically
defined HLA antigen significantly associated
with the cytotoxic action of CTL 17, the anti-
genic determinant(s) recognized by this CTL
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could at first not be determined. CTLs 18 and
19 were raised by reciprocal one-way MLC of
cells from two HLA-A, -B, -C serologically
identical, D/DR-different siblings. These
CTLs have been shown to be able to sub-
divide a panel of HLA-Bw35-positive target
cells (Goulmy et al. 1976).
To further investigate the complexity of the
HLA-Bw35 antigen and the specificity of
CTLs 9, 10, 17, 18 and 19, we compared their
cytotoxic activity against a selected panel of
HLA-Bw35-positive target cells (Figure 2).
Each of the 5 CTLs reacted with a part of this
panel. The subdivision of HLA-Bw35 by
CTLs 18 and 19 revealed that CTL 17 recog-
nized a particular subset of HLA-Bw35-posi-
tive target cells. However, CTLs 17 and 18
showed a similar, but not identical reaction
pattern. We concluded that, by using these 5
CTLs, the HLA-Bw35 antigen can be sub-
divided into at least 3 subtypes. Α fourth sub-
type of Bw35 (type D) may be represented by
the cells that were only weakly lysed by CTLs
10 and 19. Α preliminary designation of the 4
subtypes is given in Figure 2.
Cold-target Inhibition experiments
CTLs from primary MLCs are polyclonal and
may contain different population of CTLs di-
rected against distinct antigenic determinants.
Such CTLs can be subdivided into subsets of
CTL specific either for shared determinants
or for HLA-antigen subtypes (Breuning et al.
1983, Spits et al. 1982, Tekolf et al. 1982).
Because it was already known that HLA-
Bw35 can be subdivided into 2 subtypes
(Goulmy et al. 1976), it was particularly inter-
esting to test whether all third-party Bw35-
positive target cells lysed by CTL 10 could
inhibit the cytotoxic activity of these CTLs.
The results of cold-target Inhibition experi-
ments are shown in Table 2. The stimulator
cells completely inhibited the cytotoxic action
of CTL 10. The addition of cold-target cells
CTL
10 18 19 17 9
Figure 2. Cytolytic activity of fivc CTLs raised in
HLA-A, -B and -C serologically identical re-
sponder-stimulator pairs and tested against HLA-
Bw35-positive target cells from 28 unrelated indi-
viduals. E U , more than 20% 51Cr release; i S l ,
between 15 and 20% 51Cr release; I I, less than
15% 51Cr release. Α-D, arbitrary designation of
CTL-defined subtypes of HLA-Bw35.The effcctor/
target-ccll ratio was 10:1.
from the responder (cell no. 436) caused a
reduction of the lysis of 'hot'-target cells.
Such a non-specific reduction of cytotoxic
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Table 2.
Cold-target Inhibition of CTL 10 by Bw35-positive cells of 6 donors.
Cold target
cells added
202
436
191
181
345
016
144
152
HLA types
Β C DR
Subtype % Specific 51Cr release of hot target cell
ofBw35 202» 436" 191 181 345 016 144 152
no cold cells
2,3
2,3
2,33
24,32
2,3
11,32
3,28
2,3
35,60
35,60
40,35
40,35
27,35
51,35
44,35
62,35
added
3,4
3,4
3,4
3,4
1,4
4,5
3,4
1,6
6,7
4,6
4,6
1,4
4,6
1,4
1,3
Β
C
Β
C
Α
Α
Β
Β
50.0
9.0
22.7
7.9
16.3
21.6
30.5
10.4
7.0
0.0
0.1
41.8
7.9
20.3
3.3
15.2
24.3
22.4
9.2
2.6
9.6 31.5 38.6 37.8 41.4
6.7
4.4
14.7
10.3
7.0
The effector/'hot-target-cell ratio was 10:1. The cold/hot target-cell ratio was 50:1.
- Cells no. 202 are the stimulator cells of CTL 10 (Table 1).
" Cetls no. 436 are the responder cells of CTL 10 (Table 1).
activity was seen in many different cold-target
Inhibition experiments (results not shown).
Target cells not lysed by CTL 10 (cell no. 181)
reduced the cytotoxic activity on 'hot'-target
cells of the Simulator to a similar degree.
However, of 5 third-party HLA-Bw35-posi-
tive target cells lysed by CTL 10, only 3 (nos.
191, 144, 152; Bw35-'B' type) completely in-
hibited the lytic action of CTL 10. Two target
cells (nos. 345, 016; Bw35-'A' type) did not
inhibit the activity of CTL 10 against stimula-
tor cells more than cold cells of the responder
did. These results indicate that CTL 10 con-
sists of at least 2 different sets of CTLs di-
rected against distinct antigenic determinants
associated with HLA-Bw35.
As for CTL 9, the one third-party cell lysed
by this CTL (Figure 1) (cell no. 181) was able
to completely inhibit the cytotoxic activity of
CTL 9 against 'hot'-target cells of the stimula-
tor (results not shown).
Cold-target Inhibition of CTL 17 by Bw35-
positive cells of 5 donors is shown in Table 3.
Addition of cold stimulator cells (cell no. 345)
completely inhibited the cytotoxic activity of
CTL 17 against stimulator target cells and 2
third-party cells. The addition of cold re-
sponder cells (no. 265) caused some reduction
of the kill, but a major part of the cytotoxic
activity remained. Although CTL 17 showed
cytotoxic activity on hot-target cells nos. 436,
181, 016, 334 and Rc3, none of these third-
party Bw35-positive target cells was able to
completely inhibit the cytotoxic activity of
CTL 17 against stimulator cells. Moreover,
when tested against third-party 'hot'-target
cells of subtype ' C (no. 436), the cytotoxicity
of CTL 17 was more reduced by cold 'C-type'
cells than by Ά-type' cells. Conversely, when
tested on 'hot'-target cells of Bw35 subtype
Ά ' (no. 016), the cytotoxicity was more re-
duced by cold Ά-type' cells than by cold
'C-type' cells. These results indicate that CTL
17 consists of at least 2 subpopulations of
CTLs, one of which reacts with HLA-Bw35
Ά', the other with -Bw35 ' C type. However,
the percentage of cytotoxicity obtained during
these experiments is rather low (Table 3). Α
more detailed analysis of the various determi-
nants recognized by the CTL 17 would require
cloning of the subsets of CTL involved.
Discussion
In this paper, we report on the analysis of the
SUBTYPES OF HLA BW35 95
Table 3labte 3
Cold target Inhibition of CTL 17 by Bw35-positive cells of 5 donors
Cold target
cells ddded
345
265
436
181
016
334
Rc3
Α
HLA
Β
no cold cells
2,3
2,3
2,3
24,32
11,32
3,24
2,2
27b,35
27b,35
35,60
35,40
35,51
35,27"
35,44
types
C
added
1,4
1,4
3,4
3;4
1,4
4,5
DR
1 -
1,4
6,7
4,6
4,6
4,-
5 8S8
Subtype
of Bw35
Α
Β
C
C
Α
Α
Α
%
345··
46 5
10 7
312
28 8
34 2
35 4
18 0
24 5
Specific
265
4 1
- 1 4
5 1Cr
436
18 2
4 9
13 7
4 5
4 6
8 1
9 7
9 2
release
181
218
5 5
of hot
016
22 5
7 1
16 1
14 0
13 8
8 2
4 5
113
target
334
21 3
4 9
cell
Rc3
21 0
4 2
The effector/'hot'-target cell ratio was 10 1 The cold/hot target-cell ratio was 100 1
I
 Cells no 345 are the stimulator cells of CTL 17 (Table 1)
II
 These cells carry the same CTL-defined subtype of B27, "W type" (Breumng et al 1982, Breuning et al
1983)
c
 LB5 8 is a Leiden local assignment of a DR5 spht
specificity of 5 CTLs raised in combination of
HLA-A, -B and -C-identical, -D/DR-dif-
ferent responder and stimulator cells CTL 9
can be used to defme a rare vanant of HLA-
Bw35, as contrasted with CTL 10 that lysed
almost all Bw35-positive target cells tested
(Figure 1) However, by cold-target Inhibition
Table 4
Analysis of two HLA Bw35 subtypes at the clonal
level
'Clonc no E/T1 Target cells
ratio Rc 3 Rc 8C
(Bw35 'B") (Bw35 "A")
A22
B l l
C7
D3
D22
A12
40 1
10 1
40 1
7 1
20 1
7 1
- 5»
+ 4
+36
+23
+23
+ 8
+ 13
+28
- 3
+ 4
+21
+ 12
n
 Effector/target cell rdtio
b
 Ptrtentage lysis
1
 For HLA phenotypes of target cells Rc3 and Rc8,
see Table 1
The 34 "clones" that showed lysis lower than 10%
are not hsted in this Table
expenments we found that CTL 10 consisted
of dt least 2 populations of CTLs directed
against different antigenic deterrninants asso-
ciated with HLA-Bw35 (Table 2) This can be
explained by the observation that 2 additional
CTLs (CTLs 18 and 19) subdivide the panel of
Bw35-positive cells recognized by CTL 10 in 2
groups (Figure 2) Apparently, one subset of
CTL 10 lecognized an antigenic determinant
shared between almost all HLA-Bw35-posi-
tive cells ('A' as well as Έ ' types), the other
subset recognized HLA-Bw35 B-type cells
only The results of cold-target Inhibition ex-
penments support this Interpretation because
cold-target cells of Bw35-B subtype com-
pletely inhibited the cytotoxic activity of CTL
10, whereas cells of subtype Α did not (Table
2) By the use of 4 CTLs, the panel of HLA-
Bw35-positive target cells can be subdivided
into 3 groups (Α, Β and C in Figure 2) Cells
that were only weakly lysed by CTLs 10 and
19 may represent a fourth vanant of HLA-
Bw35 Until now, these subtypes have not
been recognized by HLA-typing sera (Bradley
et dl 1978, and unpubhshed observdtions)
Still further complexity is introduced by the
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iifth CTL, CTL 17 HLA-Bw35 emerged as
the target antigen for this CTL after subdivid-
mg the panel of target cells using CTLs 18 and
19 In a comparable Situation, we have been
ablc to identify, thanks to the subdivision of
HLA-B27 by CTLs (Breumng et al 1982), the
target antigen for a CTL clone which was
cross-reactive between subsets of HLA-B7-,
-B27 and -B40-positive target cells (Breumng
et al 1984) The responder used for the gen-
eration of CTL 17 was Bw35 subtype 'B', the
stimulator Bw35 subtype Ά ' However, CTL
17 were cytotoxic for both Bw35-'A' and -'C
target cells (Figure 2) Does this mean that
the stimulator cells of CTL 17 expressed a
separate type of Bw35, mcluding both Ά ' and
'C' 9 This IS unhkely, because the stimulator
cells (no 345) were not lysed by CTL 9 which
deftned Bw35 subtype 'C Thcrefore, the
antigenic determinants recognized by CTL 17
may bc different from Bw35 Ά', 'B' or ' C
Furthermore, cold-target Inhibition expen-
ments showed that CTL 17 compnse at least 2
populations of CTLs with different specifi-
cities
We can conclude that the CTLs showed a
senes of antigenic determinants hitherto not
detected by antisera Although closely associ-
ated with HLA-Bw35, these antigenic deter-
minants are as yet not precisely defined More
accurate typing for such CTL-defined anti-
genic determinants can be achieved in two
ways First, several sets of CTLs from dif-
ferent combinations of HLA-A, -B and
-C-identical donors, which recogmze the same
antigenic determinant, can be used in parallel
This approach has been applied to the typing
of CTL-defined subtypes of HLA-B27
(Breumng et al 1983) Second, the CTLs may
be expanded, and cloned by hmiting dilution,
a technique that has already provided us with
exquisitely specific, highly cytotoxic CTL
clones recognizing subtypes of HLA-A2 and
B7 (Spits et al 1982)
The results presented here do not formally
prove that the antigenic determinants recog-
nized by the CTLs and the HLA-Bw35 anti-
gen are carned by one and the same molecule
However, two subtypes of HLA-Bw35 have
also been observed by immunoprecipitation
and subsequent electrophoresis of HLA mole-
cules (H Ploegh, personal communication)
Analogous conclusions drawn from CML data
have been confirmed by biochemical analysis
of HLA-A2 (Biddison et al 1980a, Biddison
et al 1980b, Krangel et al 1983, Spits et al
1982, Vasilov et al 1983) of which 4 subtypes
have now been dehneated (van der Poel et al
1983) Similarly, CTL-defined subtypes of
HLA-B27 (Breumng et al 1982) have been
confirmed by biochemical studies (Molders et
al 1983, Vasilov et al 1983)
Little is known about CTL-defined sub-
types of HLA antigens and their association
with vanous discases Subtypes of HLA-B27
have been investigated in patients with an-
kylosing spondyhtis (Breumng et al 1982)
Both subtypes were found among such pa-
tients, indicating that the antigenic determi-
nant recognized by the subtype-speciftc CTLs,
although functional in HLA-restncted recog-
nition of virus-infected cells (Breumng et al
1982), may not be relevant for the oecurrence
of the disease However, subtypes of HLA-
Bw35 may become mteresting in this regard,
because a clear association has been found
between Bw35 and De Quervain's thyroiditis,
a disease probably caused by a virus (Nyulassy
et al 1975, Ryder et al 1979)
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